Apothecon Pharmaceuticals is committed to improving patients’ lives in purposeful ways by providing safe and cost effective generic drugs. We strive to achieve leading innovation in generic medicine by developing cost effective and focused product pipeline.
Our state of art R & D facility foot prints to almost 5200 Sq. M. Our team of experienced research scientists is constantly creating non infringing cost effective process development for generic molecules with the stringent quality standards. The dynamic and aggressive approach of our vast experienced scientists sets us apart from its competition and making its capabilities unparalleled in the industry. Team of experts is constantly working to create a healthier society through innovation in healthcare.
We are developing molecules of different therapeutic categories like nephrology, anticoagulants, anti-cholesterol, antiviral, antidotes, anesthesia, antihypertensive, anti cancer etc.
Our Analytical Development Laboratory team having well qualified, skilled and experienced analytical staff in multidisciplinary area.
Analytical Research & Development facility is well equipped with sophisticated analytical equipments.
It supports R&D Synthesis and Formulation Development using modern analytical techniques.
Analytical method development and analytical method transfer support to quality control and other manufacturing location.
Structural Elucidation for Drug substance, intermediate and isolation and characterization of impurities.
Method validation of raw material, intermediate, drug substance and drug product.
Formulation Development Department is involved in developing generic drug products for various markets.
Formulation Development team works on non infringing various dosage forms like Immediate Release tablets, Delayed Release tablets, Extended Release tablets, Hard Gelatine Capsules, Lozenges and Oral Suspensions, etc. for US, Europe, other emerging markets and Domestic market.